Dihydroartemisinin counteracts fibrotic portal hypertensionviafarnesoid X receptor-dependent inhibition of hepatic stellate cell contraction
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dihydroartemisinin counteracts fibrotic portal hypertensionviafarnesoid X receptor-dependent inhibition of hepatic stellate cell contraction
Authors
Keywords
-
Journal
FEBS Journal
Volume 284, Issue 1, Pages 114-133
Publisher
Wiley
Online
2016-11-07
DOI
10.1111/febs.13956
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-βR/ERK signaling pathway
- (2016) Qin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway
- (2016) Qin Chen et al. IUBMB LIFE
- Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism
- (2016) Wenxuan Xu et al. IUBMB LIFE
- Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension
- (2016) Rajiv Jalan et al. JOURNAL OF HEPATOLOGY
- Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries
- (2016) Alexander Adjei et al. MALARIA JOURNAL
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation
- (2016) Chunfeng Lu et al. TOXICOLOGY
- Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells
- (2015) Guiqi Qin et al. APOPTOSIS
- Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress
- (2015) Chunfeng Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Risk of infections during interferon-based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis
- (2015) Raoel Maan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Role of Ca2+-dependent and Ca2+-sensitive mechanisms in sphingosine 1-phosphate-induced constriction of isolated porcine retinal arterioles in vitro
- (2014) Takayuki Kamiya et al. EXPERIMENTAL EYE RESEARCH
- Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
- (2014) Feng Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo
- (2014) Ruchi Bansal et al. JOURNAL OF CONTROLLED RELEASE
- A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control
- (2014) Xu-Guang Zhang et al. PARASITOLOGY RESEARCH
- Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway
- (2014) X.Q. Wang et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
- (2014) Sharon Manley et al. Redox Biology
- IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet
- (2013) Xiao-Yu Luo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats
- (2013) In-Chul Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
- (2013) Len Verbeke et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- Aryl hydrocarbon receptor plays protective roles in ConA-induced hepatic injury by both suppressing IFN-γ expression and inducing IL-22
- (2013) Hiromi Abe et al. INTERNATIONAL IMMUNOLOGY
- Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation
- (2012) Yoshiaki Sunami et al. HEPATOLOGY
- Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents
- (2012) Yuko Kageyama et al. HEPATOLOGY
- Functional aspects on the pathophysiology of portal hypertension in cirrhosis
- (2012) Juan-Carlos García-Pagán et al. JOURNAL OF HEPATOLOGY
- Hepatocarcinogenesis in FXR−/−Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR Expression
- (2012) Nian Liu et al. MOLECULAR ENDOCRINOLOGY
- Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6
- (2012) Sheng-Chu Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways
- (2011) Masateru Iizuka et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Role of NF-kB, p53, and p21 in the Regulation of TNF-α Mediated Apoptosis of Lymphocytes
- (2010) N. V. Ryazantseva et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand
- (2010) Jiang Li et al. PLoS One
- The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease
- (2009) Andrea Mencarelli et al. BIOCHEMICAL PHARMACOLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation
- (2009) Barbara Renga et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Stellate Cell Contraction: Role, Regulation, and Potential Therapeutic Target
- (2008) Russell K. Soon et al. Clinics in Liver Disease
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started